Filter Results:
(414)
Show Results For
- All HBS Web
(705)
- Faculty Publications (414)
Show Results For
- All HBS Web
(705)
- Faculty Publications (414)
- January 2010 (Revised August 2012)
- Supplement
Hospital for Special Surgery (B): Continuing Challenges of Growth
By: Regina E. Herzlinger and Laura Low Ah Kee
After its successful new U.K. venture, the Hospital for Special Surgery wants to do more of the same, without decimating its core New York City facility. The case provides considerable details about the different options it is exploring. View Details
Herzlinger, Regina E., and Laura Low Ah Kee. "Hospital for Special Surgery (B): Continuing Challenges of Growth." Harvard Business School Supplement 310-077, January 2010. (Revised August 2012.)
- January 2010
- Teaching Note
MedVal Ventures, Fortis Healthcare (A), Fortis Healthcare (B), and Note on Medical Travel (TN)
Teaching Note for [308087], [308030], [308080], and [308084]. View Details
- December 2009 (Revised September 2024)
- Case
Phreesia: The Patient Intake Company
How should the co-founders of an organization that provides patient sign-in and billing services scale their company after five years of successfully targeting small private physician practices? Phreesia had deployed a direct mail and sales force strategy that resulted... View Details
Herzlinger, Regina E. "Phreesia: The Patient Intake Company." Harvard Business School Case 310-066, December 2009. (Revised September 2024.)
- Article
Health Care's Taxing Problem
Herzlinger, Regina E. "Health Care's Taxing Problem." National Review Online (August 12, 2009).
- July 2009
- Article
Limited Choices
Herzlinger, Regina E. "Limited Choices." National Review Online (July 2009).
- May 2009
- Article
Can the United States Provide Health Care For All?
- May 2009
- Article
Diagnosis
- April 2009 (Revised April 2009)
- Case
Immusol and Novartis
By: Regina E. Herzlinger, Keyne M. Monson, Juan D. Betancourt and Victor Li
Should Immusol strive to become a fully integrated pharmaceutical company? How should a small pharmaceutical company structure a deal for its novel technology with the giant Novartis? View Details
Keywords: Technological Innovation; Rights; Negotiation Deal; Negotiation Participants; Alliances; Pharmaceutical Industry
Herzlinger, Regina E., Keyne M. Monson, and Juan D. Betancourt. "Immusol and Novartis." Harvard Business School Case 303-038, April 2009. (Revised from original October 2002 version.)
- Article
Health Care Challenges for Leaders
By: R. E. Herzlinger
From ancient times to today, perceptive leaders have galvanized people by appealing to commonly shared values. Indeed, a discussion of leadership is virtually impossible without talking about values. As the articles in this issue demonstrate,Values are what animate... View Details
Herzlinger, R. E. "Health Care Challenges for Leaders." Leader to Leader, no. 47 (Winter 2008): 39–45.
- October 2008
- Case
Diagnostic Genomics
By: Regina E. Herzlinger and Mark P. Allyn
Should this gene detection firm enter the business of providing tests for the detection of genetic diseases? If so, how should it prioritize the tests it could develop? View Details
Keywords: Health Testing and Trials; Market Entry and Exit; Product Development; Genetics; Strategy; Health Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Mark P. Allyn. "Diagnostic Genomics." Harvard Business School Case 309-040, October 2008.
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040. View Details
Keywords: Health Testing and Trials; Technology; Biotechnology Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- September 2008 (Revised March 2020)
- Supplement
Medtronic: Patient Management Initiative (B)
The (B) case provides the denouement to the (A) case about Medtronic's introduction of the Chronicle and remote monitoring business. View Details
Keywords: Health Care and Treatment; Measurement and Metrics; Information Technology; Competitive Strategy; Medical Devices and Supplies Industry
Herzlinger, Regina E. "Medtronic: Patient Management Initiative (B)." Harvard Business School Supplement 309-064, September 2008. (Revised March 2020.)
- July–August 2008
- Article
Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School, Cambridge, MA. She received her bachelor's degree from MIT and her doctorate from the Harvard Business School The first woman to be tenured and... View Details
"Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare." Journal for Healthcare Quality 30, no. 4 (July–August 2008): 17–19.
- March 2008 (Revised January 2010)
- Background Note
Note on Accountability in the U.S. Health Care System
By: Regina E. Herzlinger and Michael Millenson
This note explains how health care providers, health insurers, and consumers are held accountable for their performance and the entrepreneurial opportunities thus created. View Details
Keywords: Entrepreneurship; Ethics; Insurance; Corporate Accountability; Health Care and Treatment; Demand and Consumers; Health Industry; United States
Herzlinger, Regina E., and Michael Millenson. "Note on Accountability in the U.S. Health Care System." Harvard Business School Background Note 308-111, March 2008. (Revised January 2010.)
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues. View Details
Keywords: Decision Choices and Conditions; Financing and Loans; Health Care and Treatment; Health Disorders; Medical Specialties; Expansion; Health Industry; Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- February 2008 (Revised August 2012)
- Background Note
Note on Medical Travel
By: Regina E. Herzlinger and Sara Green
Background notes for MedVal and Fortis case studies. View Details
Keywords: Cost; Health Care and Treatment; Cross-Cultural and Cross-Border Issues; Health Industry; Tourism Industry; India
Herzlinger, Regina E., and Sara Green. "Note on Medical Travel." Harvard Business School Background Note 308-084, February 2008. (Revised August 2012.)
- February 2008 (Revised August 2014)
- Case
MedVal Ventures
Is medical travel a viable business opportunity? A group of MBA students consider the pros and cons of starting a business that would send people from the U.S. to India for elective non-emergency surgeries. View Details
Keywords: Business Startups; Cost Management; Globalized Markets and Industries; Health Care and Treatment; Health Industry; Travel Industry; India; United States
Herzlinger, Regina E. "MedVal Ventures." Harvard Business School Case 308-087, February 2008. (Revised August 2014.)
- January 2008 (Revised August 2012)
- Case
Retail Sales of Health Insurance: Blue Cross Blue Shield of Florida
By: Regina E. Herzlinger and Grady Clouse
The BCBS of Florida is contemplating whether to enter the consumer-driven health care market and if so, whether to target such groups—and individuals—and in which of its geographic markets, and how. View Details
- 2009
- Book
Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure
A best seller in its category, with many printings. It has been recognized by the U.S. Chamber of Commerce as one of the books that made a difference in public policy in 2008. View Details
Herzlinger, Regina. Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure. McGraw-Hill, 2009.